Repurposed Drugs Show Promise for Intellectual Disability Linked to NCOR Mutations
No Comments on Repurposed Drugs Show Promise for Intellectual Disability Linked to NCOR Mutations
New research identifies potential treatments for intellectual disability linked to NCOR gene mutations, highlighting FDA-approved drugs spironolactone and allopregnanolone.